Suppr超能文献

美国初级保健环境中 70 岁及以上男性骨质疏松症的筛查。

Screening for osteoporosis in men aged 70 years and older in a primary care setting in the United States.

机构信息

Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

出版信息

Am J Mens Health. 2013 Jul;7(4):350-4. doi: 10.1177/1557988313478826. Epub 2013 Feb 25.

Abstract

Osteoporosis in men is an underrecognized and undertreated condition. Despite the National Osteoporosis Foundation recommending osteoporosis screening in men aged 70 years and older since 2008, screening rates in the United States remain undefined. In our study, we analyzed dual-energy X-ray absorptiometry (DXA) screening rates in a primary care setting. Overall, screening rates were low (11.3%). Although there was an increase with age in both the 10-year osteoporotic and 10-year hip fracture probabilities, no association was found between increased age and bone mineral density testing using DXA. Only 23.2% of patients were prescribed bone protective treatments. The performance of DXA screening strongly predicted prescription of bone protective treatment. Increased age raised the likelihood of bone protective treatment prescriptions; however, smokers were less likely to be prescribed these medications. As the population in the United States ages, an increased awareness of this major public health problem is warranted.

摘要

男性骨质疏松症是一种未被充分认识和治疗不足的疾病。尽管自 2008 年以来,国家骨质疏松基金会建议对 70 岁及以上男性进行骨质疏松症筛查,但美国的筛查率仍未确定。在我们的研究中,我们分析了初级保健环境中的双能 X 线吸收法(DXA)筛查率。总体而言,筛查率较低(11.3%)。尽管骨质疏松症和髋部骨折 10 年概率的 10 年发生率随着年龄的增长而增加,但 DXA 检测的骨密度测试与年龄增加之间没有关联。只有 23.2%的患者开具了骨保护治疗药物。DXA 筛查的表现强烈预测了骨保护治疗药物的开具。年龄的增加提高了骨保护治疗药物处方的可能性;然而,吸烟者开这些药物的可能性较小。随着美国人口老龄化,有必要提高对这一重大公共卫生问题的认识。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验